Search Results - "Suñer, H"

4CPS-134 Optimisation of denosumab prescription in osteoporosis patients by Salom, C, Bejarano, F, Campabadal, C, Conde, S, Castillo, L, Marco, N, Sanjuan, A, Sacanella, I, Suñer, H, Canadell, L

“…Background and importanceBisphosphonates should be the first choice for osteoporosis treatment, with lower cost and no less benefit than denosumab.Aim and…”
Get full text

4CPS-193 Suitability of the dual antiplatelet therapy to the guidelines of European society of cardiology in acute coronary syndrome by Suñer, H, Cortés Sánchez, CJ, Pascual Carbonell, D, Sanjuán Belda, A, Sacanella Anglès, I, Garcia Molina, A, Canadell Vilarrasa, L

“…Background and ImportanceThe dual antiplatelet therapy(DAPT) consisting of acetylsalicylic acid plus one P2Y12 platelet receptor inhibitor represents the first…”
Get full text

3PC-008 Slow anakinra desensitisation protocol design for delayed hypersensibility reaction by Suñer, H, Martín Marqués, M, Esteso Hontoria, O, Badia Santolaria, C, Sanjuán Belda, A, Sacanella Anglès, I, Pascual Carbonell, D, Conde Giner, S, Cortés Sánchez, CJ, Garcia Molina, A, Canadell Vilarrasa, L

“…Background and ImportanceAnakinra, a recombinant human IL-1 receptor antagonist, is indicated in rheumatoid arthritis (RA) with a good safety profile,…”
Get full text